A detailed history of Nelson, Van Denburg & Campbell Wealth Management Group, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Nelson, Van Denburg & Campbell Wealth Management Group, LLC holds 29 shares of CRL stock, worth $4,838. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29
Holding current value
$4,838
% of portfolio
0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 17, 2025

BUY
$178.58 - $220.69 $5,178 - $6,400
29 New
29 $5,000
Q1 2024

Apr 30, 2024

BUY
$203.52 - $273.43 $98,300 - $132,066
483 New
483 $130,000
Q2 2022

Aug 10, 2022

SELL
$204.13 - $302.4 $107,576 - $159,364
-527 Closed
0 $0
Q3 2021

Nov 02, 2021

SELL
$372.64 - $458.3 $9,316 - $11,457
-25 Reduced 4.53%
527 $217,000
Q2 2021

Jul 27, 2021

SELL
$294.17 - $371.65 $992,823 - $1.25 Million
-3,375 Reduced 85.94%
552 $204,000
Q1 2021

May 11, 2021

SELL
$249.67 - $299.48 $118,093 - $141,654
-473 Reduced 10.75%
3,927 $1.14 Million
Q4 2020

Feb 09, 2021

BUY
$222.0 - $252.62 $81,696 - $92,964
368 Added 9.13%
4,400 $1.1 Million
Q3 2020

Oct 20, 2020

SELL
$175.56 - $226.45 $45,645 - $58,877
-260 Reduced 6.06%
4,032 $913,000
Q2 2020

Jul 02, 2020

BUY
$118.84 - $189.72 $240,294 - $383,613
2,022 Added 89.07%
4,292 $748,000
Q3 2019

Oct 09, 2019

BUY
$125.07 - $143.67 $51,278 - $58,904
410 Added 22.04%
2,270 $300,000
Q2 2019

Aug 14, 2019

SELL
$123.4 - $148.55 $43,190 - $51,992
-350 Reduced 15.84%
1,860 $264,000
Q1 2019

May 08, 2019

BUY
$104.82 - $146.73 $75,470 - $105,645
720 Added 48.32%
2,210 $321,000
Q4 2018

Feb 13, 2019

BUY
$105.09 - $137.23 $156,584 - $204,472
1,490 New
1,490 $168,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.49B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Nelson, Van Denburg & Campbell Wealth Management Group, LLC Portfolio

Follow Nelson, Van Denburg & Campbell Wealth Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nelson, Van Denburg & Campbell Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nelson, Van Denburg & Campbell Wealth Management Group, LLC with notifications on news.